[1] PEI X Y，FANG P，HE J J.The monitoring system and information resource of the adverse drug reaction[J] .China J Mod Med（中国现代医学），2003，13(9)：150-151. [2] LIANG W N，PENG X X.The actuality of study in ADRs and countermeasure Chinese [J] .J Pharmacoepidemiol（药物流行病学杂志），2003，12(4)：179-181. [3] YAN B Y，DUAN MO H J. Tuberculosis(结核病学)[M] . Beijing：Beijing Publishing House，2003，4(1)：1146. [4] LIN X H，HUANG Z Y，LI G J，et al.Effect observation on levofloxacin combined with other drugs for re-treatment tuberculosis [J] .Strait J Preventive Med（海峡预防医学杂志），2005，11(6)：76-78. [5] WANG L.The clinical observation on the efficacy of the short-term with levofloxacin and pasiniazide in the treatment of multi-drug resistant pulmonary tuberculosis [J] .J Clin Pulmonary Med（临床肺科杂志），2006，11(1)：24-25. [6] WAN C G，ZHANG H L，WU D L. The clinical observation on the efficacy of dipasic，levofloxacin and capreomycin and protionamide in weating multi-drug resistant tuberculosis[J] .Pract Prev Med（实用预防医学），2004，11(1)：85-86. [7] JI B J.Clinical analysis of pasiniazid，ofloxacin，capreomycin and prothionamide in weating multi-drug resistant tuberculosis[J] .J Chin Antituberc Assoc（中国防痨杂志），2002，24(4)：224-226. [8] XIE H A，YANG G T，LIN S Z，et al.Modern Tuberculosis(现代结核病学)[M] .Beijing：People′s Medical Publishing House 2002，2(1)：511. [9] YAN B Y，DUAN MO H J.Tuberculosis(结核病学)[M] . Beijing Publishing House，2003，4(1)：1139.